Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Gensia Sicor and Asta Medica to develop new formulation of peptide

June 2, 1998

Techniclone restructures TNT development joint venture

May 29, 1998

Ribozyme and Roche Bioscience enter ribozyme-based research collaboration

May 27, 1998

Patent covering MEKK-related assays licensed to Cadus

May 26, 1998

New tool identified for exploring the adenosine A3 receptor

May 25, 1998

Cell Genesys granted patent covering AAV vector technology

May 25, 1998

Therapeutic Antibodies and Searle announce research collaboration

May 25, 1998

Ribozyme progresses in target validation collaboration with Schering AG

May 25, 1998

Fuisz's EA technology improves onset of action of pain drugs

May 22, 1998

New P2Y1 antagonist will facilitate further study of the receptor and its physiological role

May 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...